Based on the cost–effectiveness threshold of £30,000 or $40,000 per QALY, antiviral therapies can be recommended for influenza treatment and post-exposure prevention in high-risk patients ...
Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...